FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2144491171> ?p ?o ?g. }

• W2144491171 endingPage "88" @default.
• W2144491171 startingPage "77" @default.
• W2144491171 abstract "Abstract Purpose: The graft-versus-tumor (GVT) effect is a potent form of immunotherapy against many hematologic malignancies and some solid tumors. The beneficial GVT effect after allogeneic bone marrow transplantation (BMT) is tightly linked to its most significant complication, graft-versus-host disease (GVHD). The role of interleukin-6 (IL-6) after allogeneic BMT is not well understood. This study used a series of complementary knockout and antibody blockade strategies to analyze the impact of IL-6 in multiple clinically relevant murine models of GVHD and GVT. Experimental Design: We examined the effect of the source of IL-6 by analyzing the role IL-6 deficiency in donor T cells, donor bone marrow or in host tissues. We confirmed and extended the relevance of IL-6 deficiency on GVHD and GVT by treating BMT recipients with anti-mouse IL-6 receptor (IL-6R), MR16-1. Results: Deficiency of IL-6 in donor T cells led to prolongation of survival. Total inhibition of IL-6 with MR16-1 caused an even greater reduction in GVHD-induced mortality. The reduction in GVHD was independent of the direct effects on T effector cell expansion or donor regulatory T cells. GVT responses were preserved after treatment with MR16-1. Conclusion: MR16-1 treatment reduced GVHD and preserved sufficient GVT. Tocilizumab, a humanized anti–IL-6R monoclonal antibody (mAb), is approved in several countries including the United States and European Union for the treatment of rheumatoid arthritis and other inflammatory diseases. Blockade of IL-6 with anti–IL-6R mAb therapy may be testable in clinical trials as an adjunct to prevent GVHD in BMT patients without a significant loss of GVT. Clin Cancer Res; 17(1); 77–88. ©2010 AACR." @default.
• W2144491171 created "2016-06-24" @default.
• W2144491171 creator A5001287767 @default.
• W2144491171 creator A5003360183 @default.
• W2144491171 creator A5005929047 @default.
• W2144491171 creator A5014360240 @default.
• W2144491171 creator A5017867113 @default.
• W2144491171 creator A5030234836 @default.
• W2144491171 creator A5035807104 @default.
• W2144491171 creator A5038420195 @default.
• W2144491171 creator A5053083873 @default.
• W2144491171 creator A5070421475 @default.
• W2144491171 creator A5071643003 @default.
• W2144491171 creator A5078441495 @default.
• W2144491171 creator A5082389576 @default.
• W2144491171 creator A5082674163 @default.
• W2144491171 date "2011-01-01" @default.
• W2144491171 modified "2023-10-17" @default.
• W2144491171 title "Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation" @default.
• W2144491171 cites W1274344746 @default.
• W2144491171 cites W1481422916 @default.
• W2144491171 cites W1515437203 @default.
• W2144491171 cites W1519385930 @default.
• W2144491171 cites W1647478418 @default.
• W2144491171 cites W1904767156 @default.
• W2144491171 cites W1966738123 @default.
• W2144491171 cites W1977643414 @default.
• W2144491171 cites W1982355813 @default.
• W2144491171 cites W1983931350 @default.
• W2144491171 cites W1984748165 @default.
• W2144491171 cites W2003952091 @default.
• W2144491171 cites W2005552681 @default.
• W2144491171 cites W2008548657 @default.
• W2144491171 cites W2012379095 @default.
• W2144491171 cites W2014139188 @default.
• W2144491171 cites W2019214729 @default.
• W2144491171 cites W2032000852 @default.
• W2144491171 cites W2032386695 @default.
• W2144491171 cites W2034269086 @default.
• W2144491171 cites W2035505806 @default.
• W2144491171 cites W2036334656 @default.
• W2144491171 cites W2036736974 @default.
• W2144491171 cites W2049530839 @default.
• W2144491171 cites W2051474906 @default.
• W2144491171 cites W2054124482 @default.
• W2144491171 cites W2054839097 @default.
• W2144491171 cites W2064154796 @default.
• W2144491171 cites W2067564880 @default.
• W2144491171 cites W2068639447 @default.
• W2144491171 cites W2084326063 @default.
• W2144491171 cites W2086473484 @default.
• W2144491171 cites W2094840790 @default.
• W2144491171 cites W2101596544 @default.
• W2144491171 cites W2120852203 @default.
• W2144491171 cites W2121291476 @default.
• W2144491171 cites W2126338565 @default.
• W2144491171 cites W2134461080 @default.
• W2144491171 cites W2149055573 @default.
• W2144491171 cites W2153838226 @default.
• W2144491171 cites W2157979692 @default.
• W2144491171 cites W2161239722 @default.
• W2144491171 cites W2171799063 @default.
• W2144491171 cites W282146438 @default.
• W2144491171 cites W4246291556 @default.
• W2144491171 doi "https://doi.org/10.1158/1078-0432.ccr-10-1198" @default.
• W2144491171 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3058832" @default.
• W2144491171 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21047980" @default.
• W2144491171 hasPublicationYear "2011" @default.
• W2144491171 type Work @default.
• W2144491171 sameAs 2144491171 @default.
• W2144491171 citedByCount "153" @default.
• W2144491171 countsByYear W21444911712012 @default.
• W2144491171 countsByYear W21444911712013 @default.
• W2144491171 countsByYear W21444911712014 @default.
• W2144491171 countsByYear W21444911712015 @default.
• W2144491171 countsByYear W21444911712016 @default.
• W2144491171 countsByYear W21444911712017 @default.
• W2144491171 countsByYear W21444911712018 @default.
• W2144491171 countsByYear W21444911712019 @default.
• W2144491171 countsByYear W21444911712020 @default.
• W2144491171 countsByYear W21444911712021 @default.
• W2144491171 countsByYear W21444911712022 @default.
• W2144491171 countsByYear W21444911712023 @default.
• W2144491171 crossrefType "journal-article" @default.
• W2144491171 hasAuthorship W2144491171A5001287767 @default.
• W2144491171 hasAuthorship W2144491171A5003360183 @default.
• W2144491171 hasAuthorship W2144491171A5005929047 @default.
• W2144491171 hasAuthorship W2144491171A5014360240 @default.
• W2144491171 hasAuthorship W2144491171A5017867113 @default.
• W2144491171 hasAuthorship W2144491171A5030234836 @default.
• W2144491171 hasAuthorship W2144491171A5035807104 @default.
• W2144491171 hasAuthorship W2144491171A5038420195 @default.
• W2144491171 hasAuthorship W2144491171A5053083873 @default.
• W2144491171 hasAuthorship W2144491171A5070421475 @default.
• W2144491171 hasAuthorship W2144491171A5071643003 @default.
• W2144491171 hasAuthorship W2144491171A5078441495 @default.
• W2144491171 hasAuthorship W2144491171A5082389576 @default.
• W2144491171 hasAuthorship W2144491171A5082674163 @default.

• next